Mizuho Boosts GE HealthCare Technologies (NASDAQ:GEHC) Price Target to $96.00

GE HealthCare Technologies (NASDAQ:GEHCFree Report) had its price target upped by Mizuho from $94.00 to $96.00 in a report released on Wednesday, Benzinga reports. They currently have a buy rating on the stock.

A number of other equities research analysts have also issued reports on the company. Jefferies Financial Group started coverage on GE HealthCare Technologies in a research report on Thursday, November 30th. They issued a hold rating and a $80.00 price target for the company. UBS Group cut GE HealthCare Technologies from a neutral rating to a sell rating and decreased their price objective for the company from $86.00 to $66.00 in a report on Monday, November 27th. Finally, Morgan Stanley decreased their price objective on GE HealthCare Technologies from $78.00 to $74.00 and set an equal weight rating on the stock in a report on Monday, December 4th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, GE HealthCare Technologies has an average rating of Moderate Buy and an average target price of $84.73.

Get Our Latest Analysis on GE HealthCare Technologies

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $81.34 on Wednesday. GE HealthCare Technologies has a 12 month low of $62.35 and a 12 month high of $87.83. The stock has a 50 day moving average of $75.05 and a two-hundred day moving average of $71.27. The company has a current ratio of 1.05, a quick ratio of 0.97 and a debt-to-equity ratio of 1.18. The firm has a market cap of $37.04 billion and a P/E ratio of 26.93.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. During the same period in the previous year, the business earned $1.31 EPS. GE HealthCare Technologies’s quarterly revenue was up 5.3% on a year-over-year basis. On average, analysts expect that GE HealthCare Technologies will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 16th will be paid a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.15%. The ex-dividend date is Friday, January 12th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.97%.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. First Command Advisory Services Inc. raised its stake in shares of GE HealthCare Technologies by 36,900.0% in the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after acquiring an additional 369 shares in the last quarter. Pin Oak Investment Advisors Inc. acquired a new stake in shares of GE HealthCare Technologies in the second quarter valued at $25,000. Center for Financial Planning Inc. acquired a new stake in shares of GE HealthCare Technologies in the second quarter valued at $26,000. Householder Group Estate & Retirement Specialist LLC acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at $26,000. Finally, Legacy Financial Group LLC acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at $26,000. 79.18% of the stock is currently owned by institutional investors and hedge funds.

About GE HealthCare Technologies

(Get Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.

Further Reading

Analyst Recommendations for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.